CT
Cantai Therapeutics, Inc.
SEC filingBiotechnology · Philadelpia, PA
Amount raised$3Msold at filing
Total offering$3M
Investors in the raise3count reported to the SEC
FiledJan 21, 2026first sale Jan 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ross LeimbergExecutive Officer, Director
Errik B. AndersonExecutive Officer
Getta B. VemuriExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.